| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.00035 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.00027 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.00025 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.00026 | 1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.00011 | 1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -8.4e-05 | 1 |